Comparator Sourcing In Emerging Markets: Look Before You Leap

By Khaled El-Gendy, Fisher Clinical Services

The broad appeal of emerging markets for comparator sourcing is offset by the innumerable challenges that can arise in such regions. By addressing concerns prior to the jump into uncharted territory, risks can be minimised and common pitfalls avoided.

As the volume, size and complexity of clinical trials in emerging markets reaches record levels, the demand for reference drugs – or so-called comparators – is soaring, putting supply chain professionals under pressure to source sufficient quantities of these products against tight timeframes and budget constraints.